What intravenous antibiotic regimen should be started for a hospitalized patient with a severe skin and soft tissue infection, including dosing, alternatives, and monitoring?

Intravenous Antibiotic Regimen for Severe Hospitalized SSTI

For severe skin and soft tissue infections requiring hospitalization, start vancomycin 15 mg/kg IV every 12 hours PLUS either piperacillin-tazobactam 3.375-4.5g IV every 6-8 hours OR a carbapenem (imipenem-cilastatin 500mg IV every 6 hours, meropenem 1g IV every 8 hours, or ertapenem 1g IV every 24 hours) as empiric broad-spectrum coverage. 1

Initial Assessment and Risk Stratification

Determine infection severity immediately:

• Severe infection indicators: Systemic toxicity signs (SIRS criteria), suspicion of necrotizing fasciitis, gas gangrene, immunocompromised state, or penetrating trauma 1
• High-risk features for MRSA: Purulent drainage, known MRSA colonization, injection drug use, or prior MRSA infection 1
• Polymicrobial risk factors: Neutropenia, malignancy on chemotherapy, severe immunodeficiency, immersion injuries, animal bites 1

Empiric Antibiotic Selection Algorithm

For Severe Infections (with systemic toxicity or necrotizing features):

Primary regimen: Vancomycin 15 mg/kg IV every 12 hours PLUS one of:

• Piperacillin-tazobactam 3.375g every 6h or 4.5g every 8h IV
• Imipenem-cilastatin 500mg every 6h IV
• Meropenem 1g every 8h IV 1

This broad coverage targets MRSA, streptococci, gram-negatives, and anaerobes—the polymicrobial flora typical of severe SSTIs.

For Moderate Nonpurulent Cellulitis (systemic signs but no purulence):

If MRSA risk factors present: Vancomycin 15 mg/kg IV every 12 hours alone may suffice 1

If no MRSA risk: Cefazolin 0.5-1g IV every 8h or nafcillin/oxacillin 2g IV every 6h targets streptococci and MSSA 1, 2

Alternative Regimens:

Combination options (particularly for perineal/axillary infections):

• Ceftriaxone 1g IV every 24h + metronidazole 500mg IV every 8h
• Ciprofloxacin 400mg IV every 12h + metronidazole 500mg IV every 8h
• Levofloxacin 750mg IV every 24h + metronidazole 500mg IV every 8h 1

For penicillin allergy: Vancomycin plus aztreonam or fluoroquinolone 1

Special Situations

Necrotizing Fasciitis (Suspected or Confirmed):

Immediate surgical consultation is mandatory 1

If Group A Streptococcus documented: Switch to penicillin G 4 million units IV every 4-6h PLUS clindamycin 600-900mg IV every 8h (clindamycin inhibits toxin production) 1

Empiric coverage before culture: Continue vancomycin + piperacillin-tazobactam or carbapenem until pathogen identified 1

Fever and Neutropenia:

Vancomycin PLUS antipseudomonal coverage (cefepime, carbapenem, or piperacillin-tazobactam) is required 1

Dosing Considerations

Vancomycin monitoring: Target trough 15-20 mcg/mL for serious infections; adjust for renal function 1

Piperacillin-tazobactam: Use 4.5g every 6h (rather than every 8h) for severe infections or suspected resistant organisms 1

Carbapenems: Ertapenem 1g daily offers once-daily dosing but lacks Pseudomonas coverage; use imipenem or meropenem if Pseudomonas suspected 1

Duration and De-escalation

Treatment duration: 7-14 days for most bacterial SSTIs, with 5 days minimum if rapid improvement 1

Culture-directed therapy: Narrow antibiotics once pathogen identified and susceptibilities available 1

Clinical improvement markers: Defervescence, decreased erythema/swelling, normalized WBC typically occur within 48-72 hours 1

Critical Pitfalls to Avoid

• Don't delay surgical consultation for suspected necrotizing infection—imaging should not postpone exploration if clinical suspicion high 1, 3
• Don't use extended-spectrum antibiotics beyond 3 days without documented MDRO; recent data shows 43-57% of hospitalized SSTI patients receive unnecessary broad-spectrum coverage 4
• Don't assume bilateral lower extremity erythema is cellulitis—consider venous stasis dermatitis, which doesn't require antibiotics 5
• Don't continue vancomycin if MRSA nasal PCR negative and cultures show streptococci or MSSA—narrow to beta-lactam 1

Monitoring Parameters

• Daily assessment of infection margins (mark with pen)
• Temperature, WBC, hemodynamic stability
• Vancomycin trough levels (draw before 4th dose)
• Renal function (daily creatinine for vancomycin, piperacillin-tazobactam)
• Surgical re-evaluation if no improvement within 24-48 hours 1